Compare MYSZ & EDVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MYSZ | EDVA |
|---|---|---|
| Founded | 1999 | N/A |
| Country | Israel | |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Beverages (Production/Distribution) |
| Sector | Technology | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2M | 1.9M |
| IPO Year | 2017 | 2012 |
| Metric | MYSZ | EDVA |
|---|---|---|
| Price | $2.19 | $0.27 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 249.5K | 176.6K |
| Earning Date | 04-15-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 57.40 | 32.30 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $142,000.00 | $73,066.00 |
| Revenue This Year | $41.64 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 125.40 | N/A |
| 52 Week Low | $0.33 | $0.26 |
| 52 Week High | $4.28 | $0.32 |
| Indicator | MYSZ | EDVA |
|---|---|---|
| Relative Strength Index (RSI) | 61.99 | 12.91 |
| Support Level | $0.47 | $0.26 |
| Resistance Level | $4.28 | N/A |
| Average True Range (ATR) | 0.19 | 0.03 |
| MACD | -0.09 | -0.00 |
| Stochastic Oscillator | 41.27 | 13.50 |
My Size Inc is a fashion technology company operating an integrated portfolio of businesses designed to address the pressing challenges facing fashion brands and retailers today - size and fit accuracy, excess inventory management, circular economy solutions, and international market distribution. The company, through its subsidaries provide end-to-end support across the fashion value chain; delivers AI-driven size and fit solutions for fashion e-commerce companies. The firm has the following four segments: (i) Fashion e-commerce platform, (ii) SaaS solutions, (iii) resale platform for apparel, and (iv) wholesaling of footwear. The company generates the majority of its revenue from the fashion e-commerce platform segment.
Endovia Health Sciences Inc is building a diversified cannabinoid health sciences platform through pharmaceutical innovation, strategic partnerships and disciplined execution. Endovia acquires, develops and commercializes differentiated cannabinoid health technologies across pharmaceutical, veterinary and consumer wellness markets. Endovia's product begins with CannEpil, a cannabinoid pharmaceutical asset, and extends into veterinary development and consumer wellness as the pipeline expands.